Medi-Access Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
as on 17-11-2024
- Revenue -37.02%
(FY 2023)
- Profit -159.40%
(FY 2023)
- Ebitda -174.52%
(FY 2023)
- Net Worth -123.43%
(FY 2023)
- Total Assets -30.44%
(FY 2023)
About Medi-Access Solutions
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.50 M.
Harcharan Singh, Deepak Kaur, and Manish Walia serve as directors at the Company.
- CIN/LLPIN
U24232DL2012PTC242250
- Company No.
242250
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Medi-Access Solutions?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harcharan Singh  | Director | 13-Sep-2012 | Current |
| Deepak Kaur | Director | 13-Sep-2012 | Current |
| Manish Walia | Director | 28-May-2018 | Current |
Financial Performance and Corporate Structure Insights of Medi-Access Solutions.
Medi-Access Solutions Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.02% decrease. The company also saw a substantial fall in profitability, with a 159.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 123.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medi-Access Solutions?
In 2022, Medi-Access Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
D.H. Reen Pharmaceuticals Private LimitedActive 12 years 3 monthsHarcharan Singh and Deepak Kaur are mutual person
- Smc Publisher And Distributors Private LimitedActive 6 years 11 months
Harcharan Singh is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Jun 2015 | ₹3.50 M | Open |
How Many Employees Work at Medi-Access Solutions?
Medi-Access Solutions has a workforce of 17 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medi-Access Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medi-Access Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
